NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .

Enodia Therapeutics has raised $25m in seed funding to advance a small-molecule platform for targeted protein degradation ...

BrightHeart has raised €11m ($12.8m) to advance commercialisation efforts for its AI-based prenatal congenital heart defect ...

Medical Devices includes a session from a regulatory expert on how companies can align their research between regions.

CSA Medical has submitted a PMA application for its RejuvenAir System, a device-based therapy intended to treat chronic ...

Cardio Diagnostics has signed an agreement with Aimil, and Dr. Lal PathLabs to introduce the PrecisionCHD CHD test in India.

The US Food and Drug Administration (FDA) is moving to relax regulatory requirements for low risk health and wellness ...

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a ...

Ceribell’s LVO Stroke tool is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...

ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing ...

StimLabs has announced the launch of Allacor P, a human umbilical cord device designed for acute and chronic wound management ...